2nd Circ. Lets Lilly Off Hook In Zyprexa Diabetes Suit

Law360, New York (September 7, 2012, 7:47 PM EDT) -- The Second Circuit on Friday affirmed a win for Eli Lilly & Co. in multidistrict litigation over the antipsychotic drug Zyprexa, ruling Lilly isn't liable for failing to warn a man of diabetes risks associated with the drug because he didn't show his doctors' prescription decisions hinged on the drugmaker's warnings.

Plaintiff Arthur McElroy challenged a summary judgment ruling in favor of Lilly in a suit accusing the drugmaker of failing to warn him of the risks associated with taking Zyprexa for his schizophrenia. McElroy said...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.